1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Ortho Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of Weekly Procrit Given to Gastric or Rectal Patients Procrit (epoetin alfa) - Gastrointestinal Cancer, Rectal Cancer | Phase 3 | Terminated | M.D. Anderson Cancer Center | 50 | 2001-10-31 | 2018-10-25 |
Gastrointestinal Neoplasms (1) · Rectal Neoplasms (1)
Epoetin Alfa (1) · Erythropoietin (1)
United States (1)